Prashant Chawla

Sr. General Manager at Biological E. Limited

Speaker

Mr. Prashant Chawla is a seasoned Bioprocess Manager with over 20 years of progressive experience in drug substance manufacturing, process engineering, validation, and regulatory compliance. His career spans prestigious Indian and multinational organizations, including Hyde Engineering & Consulting, Serum Institute of India, and currently, Biological E Ltd.

With a deep-rooted expertise in vaccine bulk antigen manufacturing, Mr. Chawla has led end-to-end operations encompassing scale-up, technology transfer, and cGMP compliance for critical vaccines such as Diphtheria, Hib Conjugate Vaccine, and Typhoid Vi Polysaccharide. He has played a pivotal role in the successful manufacturing of Typhoid O2 Polysaccharide, CRM197, and CORBEVAX (COVID-19 Vaccine), steering cross-functional teams to deliver operational excellence.

Mr. Chawla has overseen technology transfers for both bacterial and recombinant antigen production, consistently optimizing production timelines and resources while ensuring alignment with stringent global regulatory frameworks, including USFDA, EU, WHO, and ANVISA standards.

In addition to his technical acumen, Mr. Chawla holds certifications in Lean Six Sigma Green Belt (LSSGB), and has pursued professional development in Managerial Economics and Operations Management.

He holds a Master’s degree in Bioprocess Engineering from ICT and a Bachelor’s degree in Chemical Engineering, complemented by multiple cGMP certifications and regulatory training credentials.